Skip to main content
Veterinary Medicines

PG-600, poudre et solvant pour solution injectable

Authorised
  • Gonadotropin, equine, chorionic
  • Gonadotropin, equine, serum

Product identification

Medicine name:
PG-600, poudre et solvant pour solution injectable
Active substance:
  • Gonadotropin, equine, chorionic
  • Gonadotropin, equine, serum
Target species:
  • Pig
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Gonadotropin, equine, chorionic
    200.00
    international unit(s)/unit(s)
    /
    1.00
    Vial
  • Gonadotropin, equine, serum
    400.00
    international unit(s)/unit(s)
    /
    1.00
    Vial
Pharmaceutical form:
  • Powder and solution for solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG03GA99
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • MSD Animal Health Innovation GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • V 817/08/08/0956
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 28/02/2024
Updated on: 29/02/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."